Evidence map›Paper›PMID 42458955›Full record

ArticleMolecular plant pathology2026

Enhanced Rice Yellow Mottle Virus Resistance via CRISPR/Cas9-Targeted Mutagenesis of the Rice eIF(iso)4G Gene.

Antony Kigaru, Elijah M Ateka, Hanu R Pappu, Everlyne M Nganga, Rosemary Murori, Mary Esther Toili, Steven Runo

Abstract read
In one paragraph

Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antony KigaruDepartment of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovation, Nairobi, Kenya.ORCID 0000-0003-1826-7777
Elijah M AtekaDepartment of Horticulture and Food Security, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Hanu R PappuDepartment of Plant Pathology, Washington State University, Pullman, Washington, USA.
Everlyne M NgangaInternational Rice Research Institute, Nairobi, Kenya.
Rosemary MuroriInternational Rice Research Institute, Nairobi, Kenya.
Mary Esther ToiliDepartment of Biochemistry, Microbiology and Biotechnology, Kenyatta University, Nairobi, Kenya.
Steven RunoDepartment of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovation, Nairobi, Kenya.ORCID 0000-0002-9043-2338

Funding

African Union Commission
6 · The paper itself

Abstract

Rice is a staple crop primarily recognised for its high content of carbohydrates and proteins. Rice yellow mottle disease (RYMD) is a destructive disease affecting rice fields in sub-Saharan Africa and is caused by the rice yellow mottle virus (RYMV). Development of virus-resistant genotypes is a highly recommended and effective approach to controlling RYMV. A genetic approach that exploits recessive mutations in susceptibility (S) genes may enhance resistance to the virus. Reports indicate that most rice genotypes grown in Kenya are vulnerable to RYMV infection. Genome editing has shown promise in enhancing agronomic traits in crops. We obtained enhanced resistance to RYMV in the Indica rice cv. IR2793-80-01 using the CRISPR-Cas9 system. The eIF(iso)4G susceptibility gene was targeted because natural mutations in this gene confer recessive resistance to RYMV. A Cas9-OseIF(iso)4G-gRNA-expressing vector targeting the eIF(iso)4G gene was introduced into rice calli via Agrobacterium-mediated transformation. Ten T

Indexed as

CRISPR-Cas SystemsDisease ResistanceEukaryotic Initiation Factor-4GGenes, PlantMutagenesisOryzaPlant DiseasesPlant ProteinsPlant VirusesMutationPlants, Genetically ModifiedEukaryotic Initiation Factor-4GPlant ProteinsCRISPR/Cas9eIF(iso)4Ggenome editingriceRYMV

Identifiers

PMID42458955
PMCPMC13373454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.